NSE - Delayed Quote INR

Ipca Laboratories Limited (IPCALAB.NS)

1,328.45 -18.80 (-1.40%)
At close: 3:30 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Premchand Godha A.C. A., B. Com., CA Executive Chairman 112.65M -- 1946
Mr. Pranay Premchand Godha CEO, MD & Executive Director 50.98M -- 1972
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. CFO, MD & Executive Director 77.54M -- 1955
Mr. Harish P. Kamath Compliance Officer, Corporate Counsel & Company Secretary -- -- 1959
Mr. Prashant Premchand Godha Executive Director 46M -- 1975
Mr. Pawan Kothari Vice President of Operations -- -- 1965
Mr. Vishnu Saran Singh Kushwaha Vice President of Technical -- -- 1968
Mr. Sunil Ghai President of Marketing -- -- 1963
Mr. Sameer S. Tamhane Senior Vice President of Human Resources -- -- 1967
Dr. Ashok Kumar President of R&D - Chemicals -- -- 1954

Ipca Laboratories Limited

48, Kandivli Industrial Estate
Kandivli (West)
Mumbai, 400067
India
91 22 6647 4444 https://www.ipca.com
Sector: 
Healthcare
Full Time Employees: 
16,167

Description

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetology, dermatology, gastroenterology, hematology, neurology, ophthalmology, rheumatology, and urology, as well as psychiatry, probiotics, respiratory, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Corporate Governance

Ipca Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Nov 22, 2023
    Ex-Dividend Date

Upcoming Events

May 27, 2024 - May 31, 2024
Ipca Laboratories Limited Earnings Call

Related Tickers

TORNTPHARM.NS Torrent Pharmaceuticals Limited
2,694.30
+0.29%
 
ALKEM.NS Alkem Laboratories Limited
4,867.65
+3.11%
 
DIVISLAB.NS Divi's Laboratories Limited
3,843.80
+0.79%
 
AUROPHARMA.NS Aurobindo Pharma Limited
1,103.40
+1.78%
 
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,079.55
+0.77%
 
MEDICO.NS Medico Remedies Limited
46.75
-2.30%
 
LAURUSLABS.NS Laurus Labs Limited
425.90
-1.96%
 
GRANULES.NS Granules India Limited
417.95
-0.04%
 
ERIS.NS Eris Lifesciences Limited
883.60
+1.55%
 
DIVISLAB.BO Divi's Laboratories Limited
3,840.75
+0.64%